Bath & Body Works (NYSE:BBWI) PT Lowered to $38.00

Bath & Body Works (NYSE:BBWI) had its price objective reduced by equities researchers at UBS Group from $52.00 to $38.00 in a research note issued on Thursday, Benzinga reports. The brokerage currently has a “neutral” rating on the stock. UBS Group’s price target indicates a potential upside of 17.72% from the stock’s previous close.

Other equities analysts have also recently issued research reports about the company. Piper Sandler decreased their price objective on Bath & Body Works from $47.00 to $39.00 and set a “neutral” rating for the company in a report on Thursday, July 11th. JPMorgan Chase & Co. raised Bath & Body Works from an “underweight” rating to a “neutral” rating and increased their price target for the company from $40.00 to $53.00 in a research report on Friday, May 17th. Citigroup lowered their price target on Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 20th. Barclays cut their price objective on Bath & Body Works from $45.00 to $32.00 and set an “equal weight” rating for the company in a report on Wednesday, August 7th. Finally, Telsey Advisory Group restated an “outperform” rating and set a $53.00 target price on shares of Bath & Body Works in a report on Wednesday. Eight research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $44.06.

Bath & Body Works Stock Down 7.0 %

NYSE:BBWI opened at $32.28 on Thursday. The company has a market cap of $7.21 billion, a P/E ratio of 8.32, a price-to-earnings-growth ratio of 1.16 and a beta of 1.85. Bath & Body Works has a twelve month low of $27.30 and a twelve month high of $52.99. The business has a 50 day moving average price of $35.91 and a two-hundred day moving average price of $42.77.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02. The business had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.54 billion. Bath & Body Works had a net margin of 11.92% and a negative return on equity of 40.00%. As a group, analysts anticipate that Bath & Body Works will post 3.29 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. GAMMA Investing LLC bought a new stake in shares of Bath & Body Works during the fourth quarter worth approximately $27,000. First Community Trust NA bought a new stake in Bath & Body Works in the 2nd quarter valued at $30,000. EverSource Wealth Advisors LLC increased its position in Bath & Body Works by 72.0% during the 4th quarter. EverSource Wealth Advisors LLC now owns 805 shares of the company’s stock worth $35,000 after buying an additional 337 shares during the period. Federated Hermes Inc. increased its position in Bath & Body Works by 17.1% during the fourth quarter. Federated Hermes Inc. now owns 1,612 shares of the company’s stock worth $70,000 after acquiring an additional 235 shares during the period. Finally, TFO Wealth Partners LLC raised its stake in Bath & Body Works by 9,664.7% in the 4th quarter. TFO Wealth Partners LLC now owns 1,660 shares of the company’s stock worth $72,000 after purchasing an additional 1,643 shares in the last quarter. 95.14% of the stock is owned by institutional investors.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.